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Abstract
Every long bone fracture in orthopedic surgery represents a possible scenario for devel-
opment of embolism complication, especially the fat embolism. There is no scientific 
explanation why fat embolism occurs and what are the hypotheses for development of 
fat embolism or the proper way of prevention, but just speculations and possible theories 
in the evolution of the clinical picture of fat embolism syndrome. Throughout this chap-
ter, the authors will explain the possible theories of development of fat embolism, risk 
factors, pathology, and pathophysiology during progress of the clinical picture and signs 
of the fat embolism syndrome and therapy.
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1. Introduction
Every long bone fracture in orthopedic surgery represents a possible scenario for develop-
ment of embolism complication, especially the fat embolism.
2. History
In 1861, fat embolism was first described by Zenker after a railroad accident and a worker who 
sustained crush syndrome injuries [1]. At the time when it was first described, it was believed 
that fat from the bone marrow, after a long bone fracture, embolized in the lungs causing pul-
monary deficiency. On the other hand, Fenger and Salisbury believed that fat embolized from 
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fractures to the brain causing death [2]. Von Bergmann first clinically diagnosed fat embolism 
in a patient with a fractured femur in 1873 [3]. Fat embolism was thoroughly monitored and 
described during World Wars I and II. It was noted by Wong and his colleagues that patients 
with long bone fractures had a couple of desaturation episodes during the day with pro-
longed period of total desaturation [4].
3. Pathophysiology of fat embolism
The pathophysiologic mechanism of fat embolism is comprised of two theories—mechanical 
obstruction and biochemical injury. After a long bone fracture, fat emboli together with eryth-
rocytes and thrombocytes can occlude pulmonary or brain blood vessels. The release of free 
fatty acids from fat causes local toxic effect on the endothelium, while the activation of platelets 
and granulocytes causes vascular incident.
Mechanical obstruction of the pulmonary blood vessels occurs because of the size of the embo-
lized particles. In a dog model, Teng and colleagues found 80% of fat droplets to be between 
20 and 40 μm, while vessels in the lungs that are smaller than 20 μm become obstructed [5]. 
Fat globules of 10–40 μm have been found after human trauma [6].
The biochemical theory suggests that mediators from the fracture site alter lipid solubility, 
causing coalescence, because normal chylomicrons are smaller than 1 μm. Many of the emboli 
have a histological composition consisting of a fatty center with platelets and fibrin adhered [7]. 
Large amounts of thromboplastin are liberated with the release of the bone marrow, leading to 
the activation of the coagulation cascade.
Peltier hypothesized that elevated serum lipase levels present after the embolization of neu-
tral fat hydrolyzes this neutral fat to free fatty acids and causes local endothelial damage in 
the lungs and other tissues, resulting in FES [8]. This chemical phase might in part explain 
the latency period seen between the arrival of embolic fat and more severe lung dysfunction. 
Elevated serum lipase levels have been reported in association with clinically fatal FES [9, 10].
Mudd and colleagues did not find any myeloid tissue in any of the lungs at autopsy in patients 
with FES and suggested that the soft tissue injury, rather than fractures, was the primary 
cause of FES [11].
4. Incidence
The incidence of fat embolism is still not completely known. From the studies done on this 
topic so far, it happens in younger patients more often with lower limb fractures. Its incidence 
rises with the number of fractured long bones and severity of suffered injuries. Chan and 
associates found an incidence of 8.75% of overt FES in all fracture patients, with a mortal-
ity rate of 2.5% [12]. The incidence rose to 35% in patients with multiple fractures. Other 
investigators reported the incidence of FES between 0.9 and 3.5% in patients with long bone 
fractures [13–15].
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5. Clinical presentation
Clinical presentation of the fat embolism syndrome starts with hypoxia, abnormalities in the 
neurological status, as well as development of petechiae that can be found in the region of 
the head, neck, and chest. Characteristic for development of petechiae is that they cannot be 
found in all patients, and some studies have shown their presentation in only 20–50% of cases. 
Also it is important to emphasize fever that follows the clinical presentation from the begin-
ning. For the survival and adequate care of the patient, it is extremely important to recognize 
the development of fat embolism syndrome at the beginning. It is known that the develop-
ment of this syndrome starts 1–2 days after the trauma in a period that can be referred to as a 
latent period. In some studies, the authors have concluded that fat embolism syndrome devel-
ops in the first 24 h (in around 60% of all cases), while in the rest of the traumatized patients, 
it can be recognized in the first 72 h.
For the proper understanding and better and faster diagnosis of fat embolism syndrome, 
Gurd and Wilson have developed a classification of the symptoms, where they have divided 
all symptoms in major or minor signs [16]. For diagnosing a fat embolism syndrome, it is 
necessary to notice one major and four minor signs that are shown in Table 1.
Nowadays, some authors in their studies have noticed the rigidity of the criteria mentioned 
above. In the study done by Lindeque and colleagues, development of the fat embolism syn-
drome was noticed with following signs: (1) pCO
2
 of more than 55 mg Hg or pH of less than 
7.3, (2) sustained respiratory rate of more than 35 breaths/min, and (3) dyspnea, tachycardia, 
and anxiety which they have suggested to be added in the criteria of Gurd and Wilson [17].
5.1. Major signs of FES
Hypoxia – even though pulmonary symptoms can be developed in a traumatized patient by 
the pulmonary embolism, heart failure, aspiration, or medication reaction, when none of the 
mentioned pathogenesis can be connected with patient’s clinical presentation, fat embolism 
syndrome must be suspected in differential diagnosis. For a patient, it is very important to be 
on an oxygen support from the time of admittance in a hospital.
Major signs Minor signs
Hypoxemia Tachycardia
Depression of the central nervous system Fever
Petechiae Fat in urine
Fat in sputum
Retinal emboli
Decreased hematocrit
Thrombocytopenia
Table 1. Major and minor signs of fat embolism syndrome.
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Neurological status – in order to be monitored on a proper way, a full neurological status 
must be examined from the time of admittance of a patient. Every deviation in neurological 
status must be a suspicion on the development of FES. By the studies published so far on 
this topic, it is noted that in around 80% of patients with FES, some alterations in neurologi-
cal status have been noticed. It is also of great importance to exclude the factors that can 
lead to changes in neurological status and that are not connected with FES (hypoxia, head 
trauma, etc.). Alterations of consciousness or seizures are considered as a bad prognostic 
sign.
Petechiae – as mentioned before, not all patients with developed fat embolism syndrome have 
petechiae as a major sign. They are presented in 20–50% of patients with FES, and their dis-
tribution can affect not only the head, neck, and anterior aspect of chest but also the axillar 
region, palate, and conjunctivae and are caused by embolic fat.
6. Treatment options and prevention
There is no strict protocol regarding possible prevention of fat embolism syndrome. It is con-
sidered that immobilization of long bone fracture, fast transport to the hospital unit, and 
immediate stabilization of the fracture can be ways to prevent the development of fat embo-
lism syndrome. Also, fluid compensation and oxygen support from the moment of admit-
tance into the hospital also reduce the risk of development of FES. It is known that oxygen 
support has value in prevention of FES.
In order to properly follow up the patient’s condition regarding development of FES, it is rec-
ommended to daily monitor blood pressure, complete blood count, blood gas values, diure-
sis, and arterial oxygen on room air together with daily clinical examination.
From the moment of admittance into the hospital, increased fluid compensation (saline, 
Ringer solution, or hypertonic glucose) and low-molecular-weight heparin or acetylsalicylic 
acid are measures that possibly prevent the development of fat embolism syndrome [18].
Some studies have shown efficiency in preventing FES by giving large doses of corticosteroids 
immediately after the injury.
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